Lexaria Bioscience (LEXX)
(Delayed Data from NSDQ)
$2.79 USD
-0.02 (-0.71%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $2.73 -0.06 (-2.15%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 11/19/24 |
---|---|
Current Quarter | -0.09 |
EPS Last Quarter | -0.13 |
Last EPS Surprise | -44.44% |
ABR | 1.00 |
Earnings ESP
|
44.44% |
---|---|
Current Year | -0.37 |
Next Year | -0.35 |
EPS (TTM) | -0.44 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.15M | NA | 0.59M | 0.79M |
# of Estimates | 2 | NA | 2 | 2 |
High Estimate | 0.15M | NA | 0.60M | 0.98M |
Low Estimate | 0.15M | NA | 0.59M | 0.60M |
Year ago Sales | 0.00M | 0.15M | 0.23M | 0.59M |
Year over Year Growth Est. | NA | NA | 162.40% | 33.22% |
Earnings Estimates
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.09 | -0.07 | -0.37 | -0.35 |
# of Estimates | 2 | 1 | 2 | 2 |
Most Recent Consensus | -0.05 | -0.05 | -0.27 | -0.28 |
High Estimate | -0.05 | -0.07 | -0.27 | -0.28 |
Low Estimate | -0.13 | -0.07 | -0.46 | -0.41 |
Year ago EPS | -0.12 | -0.13 | -1.01 | -0.37 |
Year over Year Growth Est. | 25.00% | 46.15% | 63.37% | 5.41% |
Agreement - Estimate Revisions
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Current | -0.09 | -0.07 | -0.37 | -0.35 |
7 Days Ago | -0.13 | NA | -0.46 | -0.41 |
30 Days Ago | -0.13 | NA | -0.46 | -0.41 |
60 Days Ago | -0.13 | NA | -0.46 | -0.41 |
90 Days Ago | NA | NA | -0.60 | -0.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (8/2024) |
Next Qtr (11/2024) |
Current Year (8/2024) |
Next Year (8/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.07 | -0.27 | -0.28 |
Zacks Consensus Estimate | -0.09 | -0.07 | -0.37 | -0.35 |
Earnings ESP | 44.44% | 0.00% | 26.03% | 18.84% |
Surprise - Reported Earnings History
Quarter Ending (5/2024) |
Quarter Ending (2/2024) |
Quarter Ending (11/2023) |
Quarter Ending (8/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.13 | -0.06 | -0.13 | -0.12 | NA |
Estimate | -0.09 | NA | NA | -0.17 | NA |
Difference | -0.04 | NA | NA | 0.05 | 0.01 |
Surprise | -44.44% | NA | NA | 29.41% | -7.52% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more